S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
Freshworks gets juiced on its AI customer engagement platform
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
Much of Kenya falls into darkness in the third nationwide power blackout in 3 months

Cognex (CGNX) Stock Price, News & Analysis

$38.07
+0.03 (+0.08%)
(As of 12/8/2023 ET)
Compare
Today's Range
$37.80
$38.71
50-Day Range
$34.64
$42.23
52-Week Range
$34.28
$59.51
Volume
728,123 shs
Average Volume
1.54 million shs
Market Capitalization
$6.55 billion
P/E Ratio
41.84
Dividend Yield
0.79%
Price Target
$48.50

Cognex MarketRank™ Stock Analysis

Analyst Rating
Hold
2.18 Rating Score
Upside/​Downside
27.4% Upside
$48.50 Price Target
Short Interest
Healthy
3.05% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.12
Upright™ Environmental Score
News Sentiment
1.21mentions of Cognex in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
52.17%
From $0.46 to $0.70 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.13 out of 5 stars

Computer And Technology Sector

7th out of 585 stocks

Process Control Instruments Industry

1st out of 10 stocks


CGNX stock logo

About Cognex Stock (NASDAQ:CGNX)

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to automotive, logistics, consumer electronics, medical-related, semiconductor, consumer products, food and beverage, and others, as well as through a network of distributors and integrators. Cognex Corporation was incorporated in 1981 and is headquartered in Natick, Massachusetts.

CGNX Stock Price History

CGNX Stock News Headlines

Analysts Set Cognex Co. (NASDAQ:CGNX) Price Target at $48.50
Cognex Corp CGNX
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Cognex Corporation (CGNX) Fell on a Weak Earnings Update
Forget 3M, Buy This Hot Growth Stock Instead
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Here's Why Cognex Stock Crashed in October
Q3 2023 Cognex Corp Earnings Call
Cognex (CGNX) Q3 2023 Earnings Call Transcript
Cognex Corp Q3 Profit Decreases, but beats estimates
Cognex Reports Third Quarter 2023 Results
Cognex: Waiting For An Entry Point
Cognex Completes Acquisition of Moritex Corporation
See More Headlines
Receive CGNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cognex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/31/2023
Ex-Dividend for 12/1 Dividend
11/16/2023
Dividend Payable
12/01/2023
Today
12/10/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/15/2024

Industry, Sector and Symbol

Industry
Process control instruments
Sub-Industry
Electronic Equipment & Instruments
Current Symbol
NASDAQ:CGNX
CUSIP
19242210
Employees
2,441
Year Founded
1981

Price Target and Rating

Average Stock Price Target
$48.50
High Stock Price Target
$60.00
Low Stock Price Target
$40.00
Potential Upside/Downside
+27.4%
Consensus Rating
Hold
Rating Score (0-4)
2.18
Research Coverage
11 Analysts

Profitability

Net Income
$215.52 million
Pretax Margin
20.47%

Debt

Sales & Book Value

Annual Sales
$1.01 billion
Cash Flow
$1.47 per share
Book Value
$8.34 per share

Miscellaneous

Free Float
170,248,000
Market Cap
$6.55 billion
Optionable
Optionable
Beta
1.50

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives















CGNX Stock Analysis - Frequently Asked Questions

Should I buy or sell Cognex stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 2 sell ratings, 6 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CGNX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGNX, but not buy additional shares or sell existing shares.
View CGNX analyst ratings
or view top-rated stocks.

What is Cognex's stock price target for 2024?

11 analysts have issued twelve-month price objectives for Cognex's shares. Their CGNX share price targets range from $40.00 to $60.00. On average, they expect the company's share price to reach $48.50 in the next year. This suggests a possible upside of 27.4% from the stock's current price.
View analysts price targets for CGNX
or view top-rated stocks among Wall Street analysts.

How have CGNX shares performed in 2023?

Cognex's stock was trading at $47.11 on January 1st, 2023. Since then, CGNX shares have decreased by 19.2% and is now trading at $38.07.
View the best growth stocks for 2023 here
.

Are investors shorting Cognex?

Cognex saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 5,240,000 shares, a decrease of 10.1% from the October 31st total of 5,830,000 shares. Based on an average daily volume of 1,020,000 shares, the short-interest ratio is presently 5.1 days. Approximately 3.1% of the shares of the company are short sold.
View Cognex's Short Interest
.

When is Cognex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our CGNX earnings forecast
.

How were Cognex's earnings last quarter?

Cognex Co. (NASDAQ:CGNX) announced its quarterly earnings data on Tuesday, October, 31st. The scientific and technical instruments company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.01. The scientific and technical instruments company earned $197.24 million during the quarter, compared to analyst estimates of $190.30 million. Cognex had a net margin of 17.87% and a trailing twelve-month return on equity of 8.90%.

How often does Cognex pay dividends? What is the dividend yield for Cognex?

Cognex declared a quarterly dividend on Monday, October 30th. Shareholders of record on Friday, November 17th will be paid a dividend of $0.075 per share on Friday, December 1st. This represents a $0.30 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Thursday, November 16th. This is a boost from the stock's previous quarterly dividend of $0.07.
Read our dividend analysis for CGNX
.

Is Cognex a good dividend stock?

Cognex (NASDAQ:CGNX) pays an annual dividend of $0.30 per share and currently has a dividend yield of 0.79%. The company has been increasing its dividend for 9 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 32.97%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CGNX will have a dividend payout ratio of 42.86% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CGNX.

When did Cognex's stock split?

Shares of Cognex split on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly issued shares were distributed to shareholders after the market closes on Friday, December 1st 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What is Robert Willett's approval rating as Cognex's CEO?

94 employees have rated Cognex Chief Executive Officer Robert Willett on Glassdoor.com. Robert Willett has an approval rating of 84% among the company's employees.

What other stocks do shareholders of Cognex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cognex investors own include NVIDIA (NVDA), Alibaba Group (BABA), PayPal (PYPL), Netflix (NFLX), Micron Technology (MU), Advanced Micro Devices (AMD), Arista Networks (ANET), Activision Blizzard (ATVI), Block (SQ) and Walt Disney (DIS).

Who are Cognex's major shareholders?

Cognex's stock is owned by many different retail and institutional investors. Top institutional shareholders include Bank of New York Mellon Corp (6.19%), Lazard Asset Management LLC (3.22%), American Century Companies Inc. (1.92%), Impax Asset Management Group plc (1.63%), William Blair Investment Management LLC (1.61%) and Invesco Ltd. (1.21%). Insiders that own company stock include Anthony Sun, Carl Gerst, Dianne M Parrotte, Eugene G Banucci, Jerry A Schneider, Patrick Alias, Paul Todgham and Theodor Krantz.
View institutional ownership trends
.

How do I buy shares of Cognex?

Shares of CGNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Cognex have any subsidiaries?
The following companies are subsidiares of Cognex: *CHIARO TECHNOLOGIES, AQSENSE, AssistWare Technology, Cognex Asia Inc., Cognex Canada Inc., Cognex Canada Technology Inc., Cognex Distribution, Cognex EnShape GmbH, Cognex Europe B.V., Cognex Europe Inc., Cognex Foreign Sales Corporation, Cognex Germany Aachen GmbH, Cognex Germany Inc., Cognex Goruntu Sistemleri Satis ve Ticaret Limited Sirketi, Cognex Hungary Kft., Cognex International Inc., Cognex Ireland Ltd., Cognex K.K., Cognex Korea Inc., Cognex Ltd., Cognex Mexico S.R.L.C.V., Cognex Poland z.o.o, Cognex Representacao Comercial E Participacoes Ltda., Cognex Sensors India Private Limited, Cognex Service Inc, Cognex Service Ltd., Cognex Singapore Inc., Cognex Switzerland GmbH, Cognex Taiwan Inc., Cognex Technology and Investment LLC, Cognex UK Ltd., Cognex Vietnam Company Ltd., Cognex Vision Inspection System (Shanghai) Co. Ltd., Cognex Vision Spain S.L.U., Enshape, One Vision Drive LLC, ViDi Systems, Vision Drive Inc., and Webscan Inc.
Read More
This page (NASDAQ:CGNX) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -